Cutaneous effects after prolongaded use of hydroxyurea in polycythemia Vera;Efeitos colaterais cutâneos após uso prolongado de hidroxiuréia na policitemia Vera

Anais Brasileiros de Dermatologia

Volumn 86, Issue 4, 2011, Pages 751-754

  de França, Emmanuel Rodrigues ^a   Teixeira, Márcia Almeida Galvão ^a   Matias, Kleber de Freitas ^b   Antunes, Daniela Eugenia Costa Morais ^a   Braz, Rafael de Almeida ^a   Silva, Claudia Elise Ferraz ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Hematologist of Hemope Foundation   (Brazil)

Author keywords

Hydroxyurea; Polycythemia vera; Skin manifestations

Indexed keywords

HYDROXYUREA;

AGED; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EXCISION; HISTOLOGY; HUMAN; HYPERPIGMENTATION; ICHTHYOSIS; MALE; MELANONYCHIA; MORTALITY; NAIL DISEASE; PHLEBOTOMY; POLYCYTHEMIA VERA; RADIATION PROTECTION; SKIN ATROPHY; SKIN DEFECT; SKIN ULCER; SPLENOMEGALY; SQUAMOUS CELL CARCINOMA; TOPICAL TREATMENT; XEROSIS;

AGED; ANTISICKLING AGENTS; DRUG ERUPTIONS; HUMANS; HYDROXYUREA; MALE; POLYCYTHEMIA VERA; TIME FACTORS;

EID: 80053933525     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962011000400019     Document Type: Article

References (15)

1. Friedrich S, Raff K, Landthaler M, Karrer S. Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment. Eur J Dermatol. 2004;14:343-6.
2. Haniffa MA, Speight EL. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnoses: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes. Clin Exp Dermatol. 2006;31:733-4.
3. Zargari O, Kimyai-Asadi A, Jafroodi M. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia. Pediatr Dermatol. 2004;21:633-5.
4. Dissemond J, Hoeft D, Knab J, Franckson T, Kroger K, Goos M. Leg ulcer in a patient associated with hydroxyurea therapy. Int J Dermatol. 2006;45:158-60.
5. Neynaber S, Wolff H, Plewig G, Wienecke R. Longitudinal melanonychia induced by hydroxyurea therapy. J Dtsch Dermatol Ges. 2004;2:588-91.
6. Zaccaria E, Cozzani E, Parodi A. Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms. J Dermatolog Treat. 2006;17:176-8.
7. Jeevankumar B, Thappa DM. Blue lunula due to hydroxyurea. J Dermatol. 2003;30:628-30.
8. Wiechert A, Reinhard G, Tuting T, Uerlich M, Bieber T, Wenzel J. Multiple skin cancers in a patient treated with hydroxyurea. Hautarzt. 2009;60:651-2.
9. Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, et al. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62:291-9.
10. Swindells S, Cohen CJ, Berger DS, Tashima KT, Liao Q, Pobiner BF, et al. Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens. BMC Infect Dis. 2005;5:23.
11. Steels E, Heenen M, Germaux MA, Moens JP. Cutaneous side effects of a long-term treatment by hydroxyurea. Rev Med Brux. 2006;27:39-41.
12. Hoff NP, Akanay-Diesel S, Pippirs U, Schulte KW, Hanneken S. Cutaneous side effects of hydroxyurea treatment for polycythemia vera. Hautarzt. 2009;60:783-7.
13. Saraceno R, Teoli M, Chimenti S. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject. Clin Ther. 2008;30:1324-9.
14. Soutou B; Aractingi S. Myeloproliferative disorder therapy: assessment and management of adverse events--a dermatologist's perspective. Hematol Oncol. 2009;27 (Suppl 1):11-3.
15. Linardi, C da Cruz G; Pracchia, L F; Buccheri, V. Diagnosis and treatment of polycythemia vera: Brazilian experience from a single institution. São Paulo Med J. 2008;126:52-7.